Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases

World Journal of Urology

Volumn 31, Issue 1, 2013, Pages 229-233

  Wiedemann, A ^a,b   Kaeder, M ^c   Greulich, W ^c   Lax, H ^d   Priebel, J ^d   Kirschner Hermanns, R ^e   Fusgen I ^b  

^a Evangelisches Krankenhaus Witten GmbH   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Helios Clinik Hagen Ambrock   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Lower urinary tract symptoms; Multiple sclerosis; Urodynamics

Indexed keywords

EID: 84873113990     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0820-y     Document Type: Article

References (25)

1. van der Mei IA, Simpson S Jr, Stankovich J, Taylor BV (2011) Individual and joint action of environmental factors and risk of MS. Neurol Clin 29(2): 233-255.
2. Wingerchuk DM (2011) Environmental factors in multiple sclerosis: epstein-barr virus, vitamin d, and cigarette smoking. Mt Sinai J Med 78(2): 221-230.
3. McElroy JP, Oksenberg JR (2011) Multiple sclerosis genetics 2010. Neurol Clin 29(2): 219-231.
4. Ramagopalan SV, Meier UC, Conacher M, Ebers GC, Giovannoni G, Crawford DH, McAulay KA (2011) Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis. Arch Neurol 68(4): 469-472.
5. Zhang Q, Lin CY, Dong Q, Wang J, Wang W (2011) Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev 8: 474-481.
6. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME et al (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6(9): 773-781.
7. Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 82(3): 317-322.
8. Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC (2011) Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 305: 116-120.
9. Hawkes CH (2007) Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 13(5): 610-615.
10. Zamboni P, Galeotti R (2010) The chronic cerebrospinal venous insufficiency syndrome. Phlebology 25(6): 269-279.
11. Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36(2): 109-120.
12. Greer JM, McCombe PA (2011) Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 234: 7-18.
13. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1): 121-127.
14. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58(6): 840-846.
15. Khan F, Pallant JF, Shea TL, Whishaw M (2009) Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort. Disabil Rehabil 31(19): 1567-1576.
16. Rantell A (2009) Lower urinary tract symptoms in women with multiple sclerosis: 2. Br J Nurs 18(15): 16-18.
17. Pohar SL, Jones CA, Warren S, Turpin KV, Warren K (2007) Health status and health care utilization of multiple sclerosis in Canada. Can J Neurol Sci 34(2): 167-174.
18. Koch T, Kralik D, Eastwood S, Schofield A (2001) Breaking the silence: women living with multiple sclerosis and urinary incontinence. Int J Nurs Pract 7(1): 16-23.
19. Luoto E, Jussilainen M, Sandell S (1993) Intermittent self-catheterization in multiple sclerosis. Sairaanhoitaja 1(1): 17-20.
20. Lemack GE, Hawker K, Frohman E (2005) Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation. Urology 65(5): 854-857.
21. Petersen T, Pedersen E (1984) Neurourodynamic evaluation of voiding dysfunction in multiple sclerosis. Acta Neurol Scand 69(6): 402-411.
22. Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Finazzi AE, Collura G, Vespasiani G (1999) Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 80(4): 437-441.
23. Welz-Barth A, Fusgen I, Melchior HJ (2000) 1999 rerun of the 1996 German Urinary Incontinence Survey: will doctors ever ask? World J Urol 18(6): 436-438.
24. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van KP (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21(3): 261-274.
25. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11): 1444-1452.